Clinical Trial Update: The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19 [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on using exosomes for acute respiratory distress syndrome or COVID-19 related pneumonia (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Novel Coronavirus Pneumonia
• Respiratory Distress Syndrome

Drugs mentioned

• Exosomes (exosomes)

Snippet

Sponsor: AVEM HealthCare | Conditions: Covid19, Novel Coronavirus Pneumonia | Phase 1, Phase 2 | Status: UNKNOWN